1. The anthracyclines;Weiss;Semin Oncol,1992
2. DNA topoisomerases;Chen;Annu Rev Pharmacol Toxicol,1994
3. DNA topoisomerase II as the primary target of anti-tumor anthracyclines;Zunino;Anticancer Drug Des,1990
4. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines;Animati;Mol Pharmacol,1996
5. Influence of structural modifications at the 3′ and 4′ positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance;Capranico;Mol Pharmacol,1994